Neurolite

Neurolite operates as a Swiss medical-device supplier focused on neurology and adjacent clinical and research applications. Its portfolio combines diagnostic and therapeutic equipment: EMG/nerve-conduction and evoked-potential systems, EEG and sleep diagnostics, ultrasound, Doppler monitoring and transcranial stimulation. This breadth may let the company serve multiple neurological workflows through one distributor, while its stated Swiss distribution relationships with Dantec and Natus provide recognizable product lines. Neurolite also describes integrated neuromuscular ultrasound that can be used alongside ENMG systems and incorporated into electrophysiology reporting, as well as configurable software and workflows. These are specific service and portfolio distinctions; there is not enough comparable market information to quantify market share or establish a defensible set of named competitors. Dantec and Natus are identified as distribution principals, not competitors. With no confirmed funding history or detailed employee count, its competitive position is best understood as a specialized regional distributor and solutions provider rather than a venture-scale device manufacturer.

Neurolite’s recorded founding date is Jan 1, 2011, and its operating status is active. The company’s profile describes a portfolio across neurodiagnostics, ultrasound, sleep medicine and brain stimulation, including the Neurolith® TPS System, MagPro TMS/rTMS Systems, Dantec Keypoint EMG/EP Systems and DWL Doppler Solutions. The breadth suggests development through product-line coverage and distribution rather than a clearly documented sequence of standalone product launches. No funding rounds, total funding, valuation or investor base are established, so financing cannot be used as evidence of acceleration or constraint. The trajectory is therefore consistent with an active, established specialist business, but public indicators are insufficient to determine whether it is expanding, stable or contracting.